D'AMORE, CLAUDIO
 Distribuzione geografica
Continente #
NA - Nord America 928
EU - Europa 763
AS - Asia 193
Totale 1.884
Nazione #
US - Stati Uniti d'America 926
IE - Irlanda 209
IT - Italia 141
SE - Svezia 119
UA - Ucraina 103
SG - Singapore 54
FI - Finlandia 53
HK - Hong Kong 50
CN - Cina 49
RU - Federazione Russa 42
FR - Francia 29
DE - Germania 26
VN - Vietnam 23
GB - Regno Unito 16
TR - Turchia 11
CH - Svizzera 8
PL - Polonia 8
CZ - Repubblica Ceca 3
LB - Libano 3
AT - Austria 2
BE - Belgio 2
NL - Olanda 2
AE - Emirati Arabi Uniti 1
CA - Canada 1
JP - Giappone 1
MX - Messico 1
UZ - Uzbekistan 1
Totale 1.884
Città #
Chandler 263
Dublin 209
San Mateo 104
Altamura 69
Hong Kong 50
Medford 49
Perugia 49
Lawrence 48
Princeton 48
Jacksonville 42
Wilmington 35
Andover 34
Singapore 32
Ann Arbor 25
Dong Ket 23
Beijing 22
Boardman 15
Des Moines 12
Saint Petersburg 12
Izmir 11
Dearborn 9
San Paolo di Civitate 9
Helsinki 7
Ashburn 5
Falls Church 5
Norwalk 5
Houston 3
London 3
Olomouc 3
Brussels 2
Den Haag 2
Los Angeles 2
New York 2
Woodbridge 2
Al Ain City 1
Bologna 1
Deruta 1
Frankfurt Am Main 1
Hanover 1
Hefei 1
Kunming 1
Lausanne 1
Moscow 1
Nanjing 1
Napoli 1
Phoenix 1
Redmond 1
Redwood City 1
Rovato 1
Shanghai 1
Shenyang 1
Tappahannock 1
Tokyo 1
Tolentino 1
Toronto 1
Totale 1.232
Nome #
Efficacy of the CCR5 antagonist maraviroc in reducing early, ritonavir-induced atherogenesis and advanced plaque progression in mice. 85
The bile acid receptor GPBAR1 (TGR5) is expressed in human gastric cancers and promotes epithelial-mesenchymal transition in gastric cancer cell lines 79
Diethylstilbestrol-scaffold-based pregnane X receptor modulators 68
Glucocorticoid receptor mediates the gluconeogenic activity of the farnesoid X receptor in the fasting condition 66
Preliminary structure-activity relationship on theonellasterol, a new chemotype of FXR antagonist, from the marine sponge Theonella swinhoei. 61
Dissociation of intestinal and hepatic activities of FXR and LXRα supports metabolic effects of terminal ileum interposition in rodents. 59
Design, synthesis, and biological evaluation of potent dual agonists of nuclear and membrane bile acid receptors. 59
a Farnesoid-X-Receptor (FXR)-Glucocorticoid Receptor (GR) Cascade Regulates Intestinal Innate Immunity in Response to FXR Activation 58
Discovery of sulfated sterols from marine invertebrates as a new class of marine naturalantagonists of farnesoid-X-receptor. 54
Leflunomide protects against dyslipidemia development induced by ritonavir in mice 53
FXR mediates a chromatin looping in the GR promoter thus promoting the resolution of colitis in rodents. 53
Ritonavir-induced lipoatrophy and dyslipidaemia is reversed by the anti-inflammatory drug leflunomide in a PPAR-γ-dependent manner. 52
4-Methylenesterols from Theonella swinhoei sponge are natural pregnane-X-receptor agonists and farnesoid-X-receptor antagonists that modulate innate immunity. 50
Farnesoid X receptor suppresses constitutive androstane receptoractivity at the multidrug resistance protein-4 promoter. 49
The HIV Matrix Protein p17 subverts Nuclear Receptors Expression and induces a STAT1-Dependent Proinflammatory Phenotype in Monocytes 49
Probiotics modulate intestinal expression of nuclear receptor and provide counter-regulatory signals to inflammation-driven adipose tissue activation. 49
Discovery that theonellasterol a marine sponge sterol is a highly selective FXR antagonist that protects against liver injury in cholestasis. 49
Conicasterol E, a Small Heterodimer PartnerSparing Farnesoid X Receptor Modulator Endowed with a Pregnane X ReceptorAgonistic Activity, from the Marine Sponge Theonella swinhoei 48
The HIV Matrix Protein p17 promotes the Activation of human hepatic stellate cells through interactions with CXCR2 and Syndecan-2 44
The nuclear receptor FXR regulates hepatic transport and metabolism of glutamine and glutamate 42
Binding mechanism of the farnesoid X receptor marine antagonist suvanine reveals a strategy to forestall drug modulation on nuclear receptors. Design, synthesis, and biological evaluation of novel ligands. 41
Bazedoxifene-scaffold-based mimetics of solomonsterols A and B as novel pregnane X receptor antagonists. 40
Exploitation of cholane scaffold for the discovery of potent and selective farnesoid X receptor (FXR) and G-protein coupled bile acid receptor 1 (GP-BAR1) ligands 40
SHP-dependent and -independent induction of peroxisomeproliferator-activated receptor-γ by the bile acid sensor farnesoid X receptorcounter-regulates the pro-inflammatory phenotype of liver myofibroblasts. 39
CCR5 Antagonism by Maraviroc Reduces the Potential for Gastric Cancer Cell Dissemination. 39
Epigenetic modulation by methionine deficiency attenuates the potential for gastric cancer cell dissemination. 39
Impaired Itching Perception in Murine Models of Cholestasis Is Supported by Dysregulation of GPBAR1 Signaling 38
Instruction of Intestinal Microbiota by VSL#3 Reverses NASH and Accelerated Atherosclerosis Caused by Intestinal Inflammation in ApoE(-/-) Mice 36
In vivo administration of ritonavir worsens intestinal damage caused by cyclooxygease inhibitors. 35
Total synthesis and pharmacological characterization of solomonsterol A, a potent marine pregnane-X-receptor agonist endowed with anti-inflammatory activity. 32
A Novel Source of Intestinal Damage: The HIV Protease Inhibitor Ritonavir Worsens Damage Caused by COX Inhibitors 32
Theonellasterols and conicasterols fromTheonella swinhoei. Novel marine natural ligands for human nuclear receptors. 31
Insights on pregnane-X-receptor modulation. Natural and semisynthetic steroids from Theonella marine sponges. 31
The CCR5 Antagonist Maraviroc Reduces the Potential for Gastric Cancer Dissemination in Rodent Models of Peritoneal Metastasis 29
HIV-1 infection is associated with changes in nuclear receptor transcriptome, pro-inflammatory and lipid profile of monocytes 28
The Bile Acid Receptor TGR5 Maintains Gastrointestinal Homeostasis and Its Activation Rescues From Gastrointestinal Injury Caused by ASA and NSAIDs 28
Role of Maraviroc in a dyslipidemic murine model of atherosclerosis RTV-induced 28
Reciprocal Regulation of TLRS and Nuclear Receptors: IRF-7 Dependent Regulation of FXR Mediates Counter-Regulatory Effects of TLR-9 in Colitis 26
Solomonsterol A, a marine pregnane-X-receptor agonist, attenuates inflammation and immune dysfunction in a mouse model of arthritis. 26
Modification on ursodeoxycholic acid (UDCA) scaffold. discovery of bile acid derivatives as selective agonists of cell-surface G-protein coupled bile acid receptor 1 (GP-BAR1). 26
VSL#3 Resets Insulin Signaling and Protects against NASH and Atherosclerosis in a Model of Genetic Dyslipidemia and Intestinal Inflammation. 25
The bile acid sensor FXR is required for immune-regulatory activities of TLR-9 in intestinal inflammation 24
Oxygenated polyketides from Plakinastrella mamillaris as a new chemotype of PXR agonists. 22
New tridecapeptides of the theonellapeptolide family from the Indonesian sponge Theonella swinhoei. 21
Incisterols, highly degraded marine sterols, are a new chemotype of PXR agonists. 21
Marine and semi-synthetic hydroxysteroids as new scaffolds for pregnane X receptor modulation. 20
Isoswinholide B and swinholide K, potently cytotoxic dimeric macrolides from Theonella swinhoei. 19
Phallusiasterols A and B: two new sulfated sterols from the Mediterranean tunicate Phallusia fumigata and their effects as modulators of the PXR receptor. 15
Totale 1.958
Categoria #
all - tutte 8.894
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.894


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020132 14 5 11 1 22 13 27 2 23 12 2 0
2020/2021282 1 21 15 19 107 21 13 1 26 10 20 28
2021/2022366 5 63 0 20 12 2 2 138 1 14 45 64
2022/2023801 48 166 1 106 60 74 0 36 288 1 16 5
2023/2024209 19 35 16 1 1 0 44 3 8 4 52 26
Totale 1.958